Insights

Gathering insights about Bolt…

Similar companies to Bolt

Bolt Tech Stack

Bolt uses 8 technology products and services including Google Analytics, Backdrop, jQuery Migrate, and more. Explore Bolt's tech stack below.

Google Analytics
Analytics
Backdrop
Content Management System
jQuery Migrate
Javascript Libraries
Slick
Javascript Libraries
WP Engine
Platform As A Service
Lua
Programming Languages
Bootstrap
UI Frameworks
Nginx
Web Servers

Media & News

CSE Bulletin: Stock Split - Bolt Metals Corp. (BOLT)
Toronto, Ontario--(Newsfile Corp. - Le 11 novembre/November 2024) - Bolt Metals Corp. has announced a two (2) for one (1) stock split of its issued and outstanding common shares. Each shareholder of record as of the close of business on the record date will receive one (1) additional share for each share held on such date.
Nov 11, 2024 | www.newsfilecorp.com
Bolt Biotherapeutics Presents Updated Preclinical Data for BDC-4182 and Key Learnings from Phase 1 Dose-Escalation Trial of BDC-1001 at SITC 39th Annual Meeting
BDC-4182 demonstrated compelling anti-tumor activity and an acceptable safety profile in preclinical studies BDC-4182 outperformed cytotoxic claudin 18.2 ADCs in syngeneic model Learnings from BDC-1001 data suggest Boltbody™ ISACs with enhanced immune activation could offer greater efficacy, warranting further testing REDWOOD CITY, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today presented updated preclinical data for BDC-4182, a next-generation Boltbody™ ISAC clinical candidate targeting claudin 18.2, and provided key learnings from its Phase 1 dose-escalation trial of BDC-1001 at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC), being held in Houston, Texas from November 6-10, 2024.
Nov 07, 2024 | www.globenewswire.com
Bolt Biotherapeutics, Inc. May Have Violated Securities Laws And Shareholders Are Urged To Participate In A Case With The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / September 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Bolt Biotherapeutics, Inc. ("Bolt" or "the Company") (NASDAQ:BOLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 5, 2021 through May 14, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before September 3, 2024.
Sep 06, 2024 | www.accesswire.com
The Schall Law Firm Invites Investors To Contribute To A Securities Fraud Lawsuit Against Bolt Biotherapeutics Inc
LOS ANGELES, CA / ACCESSWIRE / September 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Bolt Biotherapeutics, Inc. ("Bolt" or "the Company") (NASDAQ:BOLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 5, 2021 through May 14, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before September 3, 2024.
Sep 05, 2024 | www.accesswire.com
Bolt Biotherapeutics Announces Changes to its Board of Directors
REDWOOD CITY, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today announced the appointment of Jakob Dupont, M.D., to its Board of Directors. Dr. Dupont brings more than two decades of experience in the field of oncology and immuno-oncology. With the appointment of Dr. Dupont, Executive Partner at Sofinnova Investments, Dr. Jim Healy, M.D., Ph.D., also at Sofinnova, will be stepping down as Lead Independent Director. In addition, Frank D. Lee will be departing the Board and Brian O'Callaghan, CEO of Deep Genomics, will be assuming the role of Chair.
Sep 04, 2024 | www.globenewswire.com
Bolt Biotherapeutics Inc. May Have Violated Securities Regulations And Stakeholders Are Urged To Reach Out To The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / September 4, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Bolt Biotherapeutics, Inc. ("Bolt" or "the Company") (NASDAQ:BOLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 5, 2021 through May 14, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before September 3, 2024.
Sep 04, 2024 | www.accesswire.com
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Bolt Biotherapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - BOLT
NEW YORK , Sept. 3, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Bolt Biotherapeutics, Inc. ("Bolt" or the "Company") (NASDAQ: BOLT) and certain officers.
Sep 03, 2024 | www.prnewswire.com

Bolt's Email Address Formats

Bolt uses at least 1 format(s):

Bolt Email Formats	Example	Percentage
First@bolt.io	John@bolt.io	45%
FirstL@bolt.io	JohnD@bolt.io	7%
FLast@bolt.io	JDoe@bolt.io	3%
First@bolt.io	John@bolt.io	45%

Frequently Asked Questions

Where is Bolt's headquarters located?

Bolt's main headquarters is located at 2122 Bryant St San Francisco, California 94110 US. The company has employees across 5 continents, including North AmericaAsiaEurope.

What is Bolt's phone number?

You can contact Bolt's main corporate office by phone at

+1-281-392-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Bolt's stock symbol?

Bolt is a publicly traded company; the company's stock symbol is BOLT.

What is Bolt's official website and social media links?

Bolt's official website is bolt.io and has social profiles on LinkedIn.

How much revenue does Bolt generate?

As of December 2024, Bolt's annual revenue reached $3.8M.

What is Bolt's SIC code NAICS code?

Bolt's SIC code is 6799 - Investors, Not Elsewhere Classified NAICS code is 541330 - Engineering Services.

How many employees does Bolt have currently?

As of December 2024, Bolt has approximately 22 employees across 5 continents, including North AmericaAsiaEurope. Key team members include Vice President Sales: S. B.Partner: T. M.Co-Founder And General Partner: A. B.. Explore Bolt's employee directory with LeadIQ.

What industry does Bolt belong to?

Bolt operates in the Venture Capital and Private Equity Principals industry.

What technology does Bolt use?

Bolt's tech stack includes Google AnalyticsBackdropjQuery MigrateSlickWP EngineLuaBootstrapNginx.

What is Bolt's email format?

Bolt's email format typically follows the pattern of . Find more Bolt email formats with LeadIQ.

How much funding has Bolt raised to date?

As of December 2024, Bolt has raised $3.9M in funding. The last funding round occurred on Feb 20, 2013 for $3.9M.

When was Bolt founded?

Bolt was founded in 2013.

Bolt

Venture Capital and Private Equity PrincipalsCalifornia, United States11-50 Employees

Bolt is a pre-seed venture firm investing where the digital and physical world intersect. 

Bolt invests early and with conviction, leading or co-leading the first round of financing in over 90% of our portfolio companies. Bolt has invested in over 70 companies and is currently investing from our $82M Fund III.

Company Overview

Headquarters: 2122 Bryant St San Francisco, California 94110 US
Phone number: +1-281-392-****
Website: bolt.io
SIC Code: 6799 - Investors, Not Elsewhere Classified
Stock Symbol: BOLT
NAICS Code: 541330 - Engineering Services
Founded: 2013
Employees: 11-50

Media & News

Funding & Financials

$3.9M
Bolt has raised a total of $3.9M of funding over 1 rounds. Their latest funding round was raised on Feb 20, 2013 in the amount of $3.9M.
$10M
Bolt's revenue is in the range of $10M

Funding & Financials

$3.9M
Bolt has raised a total of $3.9M of funding over 1 rounds. Their latest funding round was raised on Feb 20, 2013 in the amount of $3.9M.
$10M
Bolt's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Bolt

DiDi

Gojek

Curb Mobility

Karhoo

Lyft

Careem

Grab

Ola

JUNO

Uber

Gett

Via

Bolt Tech Stack

Media & News

CSE Bulletin: Stock Split - Bolt Metals Corp. (BOLT)

Bolt Biotherapeutics Presents Updated Preclinical Data for BDC-4182 and Key Learnings from Phase 1 Dose-Escalation Trial of BDC-1001 at SITC 39th Annual Meeting

Bolt Biotherapeutics, Inc. May Have Violated Securities Laws And Shareholders Are Urged To Participate In A Case With The Schall Law Firm

The Schall Law Firm Invites Investors To Contribute To A Securities Fraud Lawsuit Against Bolt Biotherapeutics Inc

Bolt Biotherapeutics Announces Changes to its Board of Directors

Bolt Biotherapeutics Inc. May Have Violated Securities Regulations And Stakeholders Are Urged To Reach Out To The Schall Law Firm

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Bolt Biotherapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - BOLT

Bolt's Email Address Formats

Frequently Asked Questions

Where is Bolt's headquarters located?

What is Bolt's phone number?

What is Bolt's stock symbol?

What is Bolt's official website and social media links?

How much revenue does Bolt generate?

What is Bolt's SIC code NAICS code?

How many employees does Bolt have currently?

What industry does Bolt belong to?

What technology does Bolt use?

What is Bolt's email format?

How much funding has Bolt raised to date?

When was Bolt founded?

Bolt

Company Overview

Media & News

CSE Bulletin: Stock Split - Bolt Metals Corp. (BOLT)

Bolt Biotherapeutics Presents Updated Preclinical Data for BDC-4182 and Key Learnings from Phase 1 Dose-Escalation Trial of BDC-1001 at SITC 39th Annual Meeting

Bolt Biotherapeutics, Inc. May Have Violated Securities Laws And Shareholders Are Urged To Participate In A Case With The Schall Law Firm

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?